Evidence map›Paper›PMID 37559069›Full record

ArticleTrials2023

Goals for Adherence with Low-cost Incentives (GOALS): a protocol for a randomized controlled trial evaluating the impact of small airtime incentives on ART adherence among young people living with HIV in Kampala, Uganda.

Sebastian Linnemayr, Haijing Crystal Huang, Zachary Wagner, Faith Kemunto Onkundi, Barbara Mukasa, Mary Odiit

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05378607 (Goals for Adherence With Low-cost Incentives), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05378607 naactive not recruitingnot on this map

Goals for Adherence With Low-cost Incentives

TypeinterventionalSponsorRANDRan2022 to 2027Enrolled560ConditionsART, HIVArmsIncentivization based on gradually increasing, externally chosen adherence goals, End of year 1 adherence prize drawing, SMS motivational messages + reminder of prize drawing, Year 2 re-allocation based on year 1 performance, End of Year 2 viral suppression prize drawing
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sebastian LinnemayrRAND Corporation, Santa Monica, USA.
Haijing Crystal HuangIDinsight, San Francisco, USA. crystal.huang@idinsight.org.ORCID http://orcid.org/0000-0002-8696-557X
Zachary WagnerRAND Corporation, Santa Monica, USA.
Faith Kemunto OnkundiIDinsight, San Francisco, USA.
Barbara MukasaMildmay Uganda, Kampala, Uganda.
Mary OdiitMildmay Uganda, Kampala, Uganda.
IDinsight · USMildmay Uganda · UGRAND Corporation · US

Funding

Goals for Adherence with Low-cost Incentives (GOALS)R01HD104555 · NICHD · RAND CORPORATION · PI HUANG, HAIJING, LINNEMAYR, SEBASTIAN · 2021 to 2025
$3.3M
NICHD NIH HHS R01 HD104555
6 · The paper itself

Abstract

backgroundTreatment outcomes of HIV-positive individuals are threatened by low antiretroviral therapy (ART) adherence, a problem that is particularly acute among youth. Incentives are a promising tool to support ART adherence, but traditional incentive designs rewarding uniformly high levels of the desired health behavior may demotivate those with low levels of the behavior. In this study, we investigate the effectiveness of alternative approaches to target-setting for incentive eligibility using subgoals (i.e., individual-specific, interim targets leading up to the optimal target). METHODS /

designWe will enroll 628 HIV-positive youth between ages 15 and 30 into a 3-year randomized controlled trial. Participants will be randomized 1:1:1:1 to a control arm or one of three intervention arms (n = 157 each) that allow them to enter a prize drawing for small incentives if their ART adherence meets the given goal. In the first arm (T1, assigned subgoal), goals will be externally assigned and adapted to their initial adherence level. In the second arm (T2, participatory subgoal), participants can set their own interim goals. In the third arm (T3, fixed goal), all participants must reach the same target goal of 90% adherence. T1 and T2 participants are required to reach 90% adherence by month 12 to participate in a larger prize drawing. The control group receives the usual standard of care. All four groups will receive weekly motivational messages; the three treatment groups will additionally receive reminders of their upcoming prize drawing. Adherence will be measured continuously throughout the intervention period using electronic devices and for 12 months post-intervention. Surveys will be conducted at baseline and every 6 months. Viral loads will be measured annually. The primary outcome is Wisepill-measured adherence and a binary measure for whether the person took at least 90% of their pills. The secondary outcome is the log-transformed viral load as a continuous measure. DISCUSSION: Our study is one of the first to apply insights about the psychology and behavioral economics of goal-setting to the design of incentives, by testing whether conditioning the eligibility threshold for incentives on subgoals (interim goals leading up to the ultimate, high goal) improves motivation and adherence more than setting a uniformly highly goal, and a comparison group.

trial registrationClinicalTrials.gov NCT05378607. Date of registration: May 18, 2022.

Indexed as

HIV InfectionsMotivationAdolescentAnti-Retroviral AgentsGoalsHumansMedication AdherenceRandomized Controlled Trials as TopicUgandaAnti-Retroviral AgentsBehavioral EconomicsGlobal HealthGoalsHIV/AIDSIncentivesRandomized controlled trialUganda

Identifiers

PMID37559069
PMCPMC10410910
OpenAlexW4385703528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.